Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 25, 2007 Ryan Fuhrmann	The Latest Procedure From Quest Diagnostics Quest Diagnostics took a hit earlier this year from the loss of a major contract, but the lab testing firm isn't down for the count.
The Motley Fool February 8, 2007 Rich Duprey	Foolish Forecast: LabCorp Tests Positive The clinical lab-testing outfit is set to report its fourth-quarter 2006 earnings. Investors, here is what you can expect to see.
The Motley Fool July 26, 2007 Ryan Fuhrmann	LabCorp Leaps Forward LabCorp continues to fire on all cylinders. Investors, take note.
The Motley Fool October 5, 2006 Rich Smith	Great Chemistry at Lab Corp UnitedHealth Group has canceled its lab-testing contract with Quest and named Lab Corp. as its new service provider. This is an interesting situation for investors.
The Motley Fool February 4, 2011 Brian Orelli	Glaxo Sold Quest Shares. Should You? Glaxo has somewhere else to spend the capital. Do you?
The Motley Fool February 15, 2007 Ryan Fuhrmann	LabCorp Takes Names Things are going well at LabCorp, but not so well at Quest Diagnostics. Still, the long-term attractiveness of the lab testing industry is favorable as the industry consolidates and demographics support increasing healthcare services.
The Motley Fool March 12, 2007 Ryan Fuhrmann	Esoteric Results at Bio-Reference Labs Bio-Reference Labs is a small firm in the lab-testing field, but worth a look from investors.
Managed Care April 2007 Scott Kober	Managed Care Seeks More from Clinical Laboratories Contracting advantage has sometimes been with the nationwide labs, but health plans are getting serious about price, service, and patient data.
The Motley Fool April 20, 2007 Ryan Fuhrmann	Diagnosing Quest Diagnostics Quest should recover from a recent, painful contract loss. Shares trade for a reasonable 17.5 times earnings, and even lower multiple of free cash flow.
The Motley Fool April 23, 2008 Morgan Housel	UnitedHealth: Bargain or Value Trap? A dismal start to 2008 sent the insurer's shares tumbling, and the news keeps getting worse and worse.
The Motley Fool March 31, 2011 David Williamson	Embarking on a Profitable Quest Quest Diagnostics has been busy, snapping up a pair of smaller players and seeing its share price recover to near 52-week highs. Let's take a look at what these acquisitions mean going forward.
The Motley Fool February 16, 2006 Stephen D. Simpson	Lab Corp Doesn't Pass the Test Lab Corp may be a well-run company, but there just isn't enough room in the stock price.
The Motley Fool December 29, 2006 Billy Fisher	2006 in Review: CIGNA A disappointing start didn't keep the health insurer down. CIGNA shareholders can hope for another strong year in 2007.
The Motley Fool July 24, 2008 Brian Orelli	UnitedHealth Looking Healthier UnitedHealth Group isn't quite as sick as it appeared earlier this month, when it slashed yearly guidance by as much as $0.60 per share.
The Motley Fool October 24, 2006 Ryan Fuhrmann	LabCorp's Positive Results The good times continue. After taking a major client from Quest Diagnostics, the company reports strong third-quarter earnings.
The Motley Fool January 22, 2010 Brian Orelli	UnitedHealth: Beats Earnings, and Gets Beat Down? UnitedHealth was healthy last quarter, but on Wall Street, it's the future that counts.
The Motley Fool March 7, 2008 Brian Orelli	Insurers' Tarnished Reputations Shine Find out which ones rank lowest and why it doesn't matter.
The Motley Fool July 24, 2006 Ryan Fuhrmann	The Quest for Market Share Quest Diagnostics' second-quarter earnings mostly meet expectations. What might the future hold for investors?
The Motley Fool April 12, 2007 Rich Duprey	Foolish Forecast: Checking UnitedHealth's Vitals The health services provider will report its first-quarter 2007 financial results shortly. Investors, here is what you can expect to see.
The Motley Fool August 2, 2006 Stephen D. Simpson	CIGNA Stands Out A health insurance company actually pleases Wall Street. Who knew? Investors, take note.
The Motley Fool October 22, 2007 Billy Fisher	An Unwavering Approach at UnitedHealth Group UnitedHealth Group repurchases $2 billion of shares during Q3. Their disciplined pricing approach has enabled the company to consistently improve operating margins.
The Motley Fool May 28, 2009 Brian Orelli	When All Else Fails Save the customer money so they can give it to you.
The Motley Fool January 15, 2009 Brian Orelli	A Clean Bill of Health in 2009 UnitedHealth settles a few lawsuits to start the new year.
The Motley Fool November 7, 2006 Billy Fisher	Vitals Strong at UnitedHealth The health-care company's stock price is back up on increased third-quarter profits.
The Motley Fool January 22, 2009 Brian Orelli	UnitedHealth Says Good Riddance to 2008 For 2009 the company is looking for earnings essentially flat compared to last year. That doesn't seem so bad, considering that it's expecting to lose as many as 1.5 million members as the unemployment rate grows.
The Motley Fool April 22, 2009 Brian Orelli	UnitedHealth Rocks; Its Stock Doesn't With all the good news floating around, why is UnitedHealth still trading at 7.3 times the middle of this year's guidance? Alas, there's still plenty of uncertainty hanging over the company.
The Motley Fool February 6, 2009 Brian Orelli	Stocks Doubling? In This Market? Cigna, like other health insurers, lowered guidance for next year, but if it can hit the new targets it'll still be a wild improvement from last year.
The Motley Fool January 27, 2009 Brian Orelli	Testing a Recession-Resistant Hypothesis Quest Diagnostic looks poised for growth even in bad times.
The Motley Fool May 29, 2009 Brian Orelli	The "Naughty List" You Want Your Company On Athenahealth is out with its annual review of how quickly health insurers are paying the claims that doctors make for services.
The Motley Fool September 19, 2008 Brian Orelli	Health Insurers Are Not AIG Health insurers get hammered this week.
The Motley Fool February 14, 2006 Stephen D. Simpson	CIGNA Seeks Stability CIGNA has a fundamentally different model from most other health insurers, and that's both good and bad. Investors, do your own due diligence and decide for yourselves if this is a buy.
The Motley Fool October 29, 2009 Brian Orelli	WellPoint Sick for Another Year Good luck in 2011?
The Motley Fool April 7, 2009 Brian Orelli	Thanks for Nothing, CMS Insurers like Humana, Coventry Health Care, and UnitedHealth Group are going to have to raise the prices of their Medicare Advantage plans to keep their margins at a reasonable level.
The Motley Fool October 21, 2009 Brian Orelli	When Fundamentals Don't Matter UnitedHealth Group had a robust quarter. Even as unemployment drove membership rolls lower, the company topped analyst estimates by keeping costs down. Alas, none of this will matter much if Uncle Sam steps in.
The Motley Fool June 15, 2005 Bobby Shethia	A New Test for Quest The medical testing leader hopes to improve its steady performance via the rapidly growing gene-testing market. But sustained growth will require hefty capital expenditures. Investors, take note.
The Motley Fool March 9, 2007 Ryan Fuhrmann	Referencing Bio-Reference's Q1: Fool by Numbers The Northeastern clinical lab test provider released first-quarter 2007 results. Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool June 28, 2007 Billy Fisher	A Strong Start for Big Health Care A look at how four blue-chip insurers have fared in the first half of 2007. Aetna... CIGNA... UnitedHealth... WellPoint...
The Motley Fool September 6, 2007 Ryan Fuhrmann	Bio-Reference Labs Passes the Test Small-cap lab-testing firm Bio-Reference Labs third-quarter results beat analysts projections by a decent margin, again proving it can compete with the big boys in the highly competitive New York metro area.
The Motley Fool July 21, 2005 W.D. Crotty	The Lab Is Fab Laboratory Corporation of America produces more healthy results. Quest is a better value today based on earnings growth, but both companies are an excellent bet.
The Motley Fool August 25, 2008 Brian Orelli	Health Insurers Head to China Health insurers are seeking out untapped regions like China for the potential to fuel further expansion.
The Motley Fool July 3, 2008 Brian Orelli	UnitedHealth Isn't Healthy On top of a $0.40-per-share cut in yearly guidance last quarter, the health insurer announces that it's slashing guidance by as much as another $0.60 per share.
The Motley Fool April 19, 2007 Ryan Fuhrmann	Quest Diagnostics Becomes Un-United: Fool by Numbers The lab-testing firm released first-quarter 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool April 5, 2004 Alyce Lomax	Cigna's Good Medicine Cigna said that its better outlook is due to greater efficiency and better management of medical costs. It also touted some new product initiatives that are surely a way to try to retain membership as well as woo new members.
The Motley Fool April 27, 2005 Tim Hanson	Quest for Value and Growth Quest Diagnostics, a consistent winner, could be good medicine for your portfolio.
The Motley Fool May 8, 2006 Tom Taulli	Quest Software: Hugging Microsoft By expanding its products to the Microsoft line, the software company should see more growth. Investors, take note.
The Motley Fool October 17, 2011	Laboratory Corp. of America Holdings Earnings Preview Laboratory Corp. of America Holdings will unveil its latest earnings on Thursday, October 20, and analysts predict a rise of 10% in revenue.
The Motley Fool March 12, 2004 Alyce Lomax	Aetna's Picture of Health For the second time in very recent memory, Aetna (NYSE: AET) raised its guidance today, pushing its stock to a new 52-week high. The health insurance provider has suffered travails over the last several years, and investors apparently took the news as an added sign that things are on the mend.
The Motley Fool September 5, 2007 Ryan Fuhrmann	Foolish Forecast: A Test From BioReference Labs In advance of lab-testing firm BioReference Labs Q3 earnings report, analysts are predicting another quarter of double-digit earnings for the small but fast-growing regional company.
The Motley Fool May 3, 2006 Stephen D. Simpson	CIGNA's Tradeoffs CIGNA's guesses on current trends could equal long-term success. Even with conservative estimates, the stock does look like it might be something of a bargain.
The Motley Fool October 25, 2010 Rich Smith	This Just In: Upgrades and Downgrades Standpoint Capital believes that ExxonMobil, Quest Diagnostics, and Lockheed Martin have nowhere to go but up.